European Commission Approves Merck's KEYTRUDA® as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma Following Surgery Pharmaceutical Investing
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer Life Science Investing
Gilead Announces Partial Clinical Hold for Studies Evaluating Magrolimab in Combination With Azacitidine Pharmaceutical Investing
Numinus to Participate in Citi's Psychedelic Drug Call Series on February 2, 2022 Pharmaceutical Investing
Avricore Health CEO and Special Guests Join Radius Research for Investor Update Pharmaceutical Investing
 Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age Pharmaceutical Investing
